We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Pushes Back AdComm Meetings, Including One to Discuss First OTC Birth Control Pill in U.S.
FDA Pushes Back AdComm Meetings, Including One to Discuss First OTC Birth Control Pill in U.S.
The FDA is pushing off or rescheduling several advisory committee meetings this week — including one to consider what could become of the first over-the-counter (OTC) daily oral contraceptive in the U.S., Opill.